Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
PEG 3350 Laxatives: FDA Allows Firms 6 Months To Make Their Case For Rx Products
Apr 17 2018
•
By
Malcolm Spicer
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from United States
More from North America